Pfizer and BioNTech have signed an agreement to produce their coronavirus vaccine in Brazil with Eurofarma Laboratórios. Eurofarma will produce more than 100 million doses of the vaccine per year. The drug will be shipped to Latin America. Production is scheduled to begin next year.